Baytril 50 mg/ml Solution for Injection

Država: Irska

Jezik: engleski

Izvor: HPRA (Health Products Regulatory Authority)

Aktivni sastojci:

Enrofloxacin

Dostupno od:

Elanco GmbH

ATC koda:

QJ01MA90

INN (International ime):

Enrofloxacin

Doziranje:

50 milligram(s)/millilitre

Farmaceutski oblik:

Solution for injection

Tip recepta:

POM: Prescription Only Medicine as defined in relevant national legislation

Područje terapije:

enrofloxacin

Status autorizacije:

Authorised

Datum autorizacije:

1988-10-01

Svojstava lijeka

Health Products Regulatory Authority
16 October 2020
CRN009PV6
Page 1 of 6
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Baytril 50 mg/ml Solution for Injection
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
One ml solution contains:
ACTIVE SUBSTANCE:
Enrofloxacin: 50 mg
EXCIPIENT(S):
n-Butyl alcohol: 30 mg.
For the full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Solution for injection.
Clear light yellow solution.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Cattle (calves), sheep, goats, pigs, dogs and cats.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Calves
Treatment of infections of the respiratory tract caused by
enrofloxacin susceptible strains of _Pasteurella multocida,
Mannheimia_
_haemolytica_ and _Mycoplasma _spp.
Treatment of infections of the alimentary tract caused by enrofloxacin
susceptible strains of _Escherichia coli._
Treatment of septicaemia caused by enrofloxacin susceptible strains of
_Escherichia coli._
Treatment of acute mycoplasma-associated arthritis due to enrofloxacin
susceptible strains of _Mycoplasma bovis._
Sheep
Treatment of infections of the alimentary tract caused by enrofloxacin
susceptible strains of _Escherichia coli._
Treatment of septicaemia caused by enrofloxacin susceptible strains
of_ Escherichia coli._
Treatment of mastitis caused by enrofloxacin susceptible strains of
_Staphylococcus aureus_ and _Escherichia coli._
Goats
Treatment of infections of the respiratory tract caused by
enrofloxacin susceptible strains of _Pasteurella multocida_ and
_Mannheimia haemolytica_.
Treatment of infections of the alimentary tract caused by enrofloxacin
susceptible strains of _Escherichia coli._
Treatment of septicaemia caused by enrofloxacin susceptible strains of
_Escherichia coli_.
Treatment of mastitis caused by enrofloxacin susceptible strains of
_Staphylococcus aureus_ and _Escherichia coli._
Pigs:
Treatment of infections of the respiratory tract caused by
enrofloxacin susceptible strains of _Pasteurella multocida_,
_Mycoplasma_
s